دورية أكاديمية
أعرض في EDS

Fatigue in patients with acquired brain damage.

التفاصيل البيبلوغرافية
العنوان: Fatigue in patients with acquired brain damage.
عنوان ترانسليتريتد: La fatiga en el daño cerebral sobrevenido.
المؤلفون: Juárez-Belaúnde A; Unidad Avanzada de Neurorrehabilitación, Hospital Los Madroños, Madrid, España. Electronic address: alan.juarez@lmh.es., Orcajo E; Unidad Avanzada de Neurorrehabilitación, Hospital Los Madroños, Madrid, España., Lejarreta S; Unidad Avanzada de Neurorrehabilitación, Hospital Los Madroños, Madrid, España., Davila-Pérez P; Servicio de Neurofisiología, Hospital Los Madroños, Madrid, España., León N; Unidad Avanzada de Neurorrehabilitación, Hospital Los Madroños, Madrid, España., Oliviero A; Unidad Avanzada de Neurorrehabilitación, Hospital Los Madroños, Madrid, España; Servicio de Neurofisiología, Hospital Los Madroños, Madrid, España; Grupo FENNSI, Hospital Nacional de Parapléjicos, SESCAM, Toledo, España.
المصدر: Neurologia [Neurologia (Engl Ed)] 2021 Sep 15. Date of Electronic Publication: 2021 Sep 15.
Publication Model: Ahead of Print
نوع المنشور: Journal Article; Review
اللغة: English; Spanish; Castilian
بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 101778590 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2173-5808 (Electronic) Linking ISSN: 21735808 NLM ISO Abbreviation: Neurologia (Engl Ed)
أسماء مطبوعة: Original Publication: [Barcelona] : Elsevier España
مستخلص: Fatigue is a complex, multidimensional syndrome that is prevalent in patients with acquired brain damage and has a negative impact on the neurorehabilitation process. It presents from early stages after the injury, and may persist over time, regardless of whether sequelae have resolved. Fatigue is conditioned by upper neuronal circuits, and is defined as an abnormal perception of overexertion. Its prevalence ranges from 29% to 77% after stroke, from 18% to 75% after traumatic brain injury, and from 47% to 97% after brain tumours. Fatigue is associated with factors including female sex, advanced age, dysfunctional families, history of specific health conditions, functional status (eg, fatigue prior to injury), comorbidities, mood, secondary disability, and the use of certain drugs. Assessment of fatigue is fundamentally based on such scales as the Fatigue Severity Scale (FSS). Advances have recently been made in imaging techniques for its diagnosis, such as in functional MRI. Regarding treatment, no specific pharmacological treatment currently exists; however, positive results have been reported for some conventional neurorehabilitation therapies, such as bright light therapy, neurofeedback, electrical stimulation, and transcranial magnetic stimulation. This review aims to assist neurorehabilitation professionals to recognise modifiable factors associated with fatigue and to describe the treatments available to reduce its negative effect on patients.
(Copyright © 2021 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.)
فهرسة مساهمة: Keywords: Acquired brain damage; Brain tumour; Daño cerebral sobrevenido; Encefalopatía; Encephalopathy; Fatiga; Fatigue; Head trauma; Ictus; Stroke; Traumatismo cráneo encefálico; Tumor cerebral
تواريخ الأحداث: Date Created: 20210920 Latest Revision: 20240220
رمز التحديث: 20240220
DOI: 10.1016/j.nrl.2021.05.011
PMID: 34538507
قاعدة البيانات: MEDLINE
الوصف
تدمد:2173-5808
DOI:10.1016/j.nrl.2021.05.011